Clinician-Administered PTSD Scale for DSM-5

Author(s):  
Frank W. Weathers ◽  
Michelle J. Bovin ◽  
Daniel J. Lee ◽  
Denise M. Sloan ◽  
Paula P. Schnurr ◽  
...  
Keyword(s):  
Dsm 5 ◽  
SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A411-A412
Author(s):  
K I Oliver ◽  
J A Hinton ◽  
C Daffre ◽  
J Dominguez ◽  
J Seo ◽  
...  

Abstract Introduction Individuals with posttraumatic stress disorder (PTSD) exhibit autonomic hyperarousal and nightmares. We hypothesized that REM density (REMD) and REM heart rate variability would predict self-reported hyperarousal, nightmares, and PTSD diagnosis in trauma-exposed individuals. Methods Ninety-nine individuals (aged 18-40, 68 females) exposed to a DSM-5 PTSD criterion-A trauma within the past two years (48 meeting PTSD criteria) completed a night of ambulatory polysomnography (PSG) preceded by an acclimation night. REMD in scored sleep recordings were computed using the Matlab program written by Benjamin Yetton. Indices of parasympathetic tone during REM were computed using Kubios software and included Average Root Mean Square of the Successive Differences (RMSSD) and High Frequency power (HFpower). Participants completed two weeks of sleep diaries with nightmare questionnaire and completed the Clinician-Administered PTSD Scale (CAPS-5) and the PTSD Checklist for DSM-5 (PCL-5). Hyperarousal-item scores were computed from the PCL-5 without the sleep item (PCLhyp) and from the CAPS-5 (CAPShyp), and these scores (with their sleep items) were combined into a Composite Hyperarousal Index (CHI). Nightmare rate was the proportion of sleep diaries reporting a nightmare. Simple regressions measured associations among REMD, REM parasympathetic indices, hyperarousal measures, and nightmare rate. Results REMD did not significantly predict PTSD diagnosis or hyperarousal scores but did predict decreased parasympathetic activity for both RMSSD (p= 0.002, R= -0.316) and HFpower (p= 0.016 R= -0.250). REMD predicted increased nightmare rate (p= 0.011 R= 0.262). Parasympathetic tone was negatively correlated with CAPShyp, PCLhyp, and CHI for both RMSSD (p= 0.04, 0.011, <0.000, respectively) and HFpower (p= 0.051, 0.021, 0.010, respectively). Lower parasympathetic tone also predicted PTSD diagnosis with both RMSSD (p=0.012, t=2.559) and HFpower (p=0.010, t=2.627), but did not predict nightmare rate. Conclusion REMD predicted decreased parasympathetic tone and higher nightmare rate. Parasympathetic tone, but not REMD, predicted hyperarousal and PTSD diagnosis. Support R01MH109638


2018 ◽  
Author(s):  
Manon A. Boeschoten ◽  
Niels Van der Aa ◽  
Anne Bakker ◽  
F. Jackie June Ter Heide ◽  
Marthe C. Hoofwijk ◽  
...  
Keyword(s):  
Dsm 5 ◽  

2018 ◽  
Vol 234 ◽  
pp. 256-260 ◽  
Author(s):  
C. Laurel Franklin ◽  
Amanda M. Raines ◽  
Jessica L. Chambliss ◽  
Jessica L. Walton ◽  
Kelly P. Maieritsch
Keyword(s):  
Dsm 5 ◽  

2022 ◽  
Author(s):  
Marjolaine Rivest-Beauregard ◽  
Alain Brunet ◽  
Louise Gaston ◽  
Samantha Al Joboory ◽  
Marion Trousselard ◽  
...  

2018 ◽  
Author(s):  
Joshua C. Hunt ◽  
Samantha A. Chesney ◽  
Terrence D. Jorgensen ◽  
Nicholas R. Schumann ◽  
Terri A. deRoon-Cassini
Keyword(s):  
Dsm 5 ◽  

BMJ Open ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. e036078 ◽  
Author(s):  
Jan-Peter Spies ◽  
Marcella Lydia Woud ◽  
Henrik Kessler ◽  
Heinrich Rau ◽  
Gerd Dieter Willmund ◽  
...  

IntroductionThe aim of this study is to investigate the diagnostic accuracy, psychometric properties and clinical utility of the German version of the Clinician-Administered Post-Traumatic Stress Disorder (PTSD) Scale for Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) (CAPS-5) in routine clinical settings.Methods and analysisThis study is a non-interventional, multitrait–multimethod design, multicentre study that will be carried out at German civil and military inpatient and outpatient clinics. A total sample size of n=219 participants who have experienced at least one traumatic event according to criteria as defined in the DSM-5 will be recruited. For the investigation of the diagnostic accuracy and clinical utility of the CAPS-5, participants will be categorised into one of three groups, depending on their traumatic experiences and post-traumatic symptomatology: (1) monotraumatisation with PTSD; (2) multiple traumatisation with PTSD and (3) traumatisation without PTSD. Interviews will be conducted face to face by interviewers in routine clinical settings. All participants will also be asked to complete a comprehensive set of questionnaires in order to investigate different facets of construct validity and clinical utility. First, differences between all three groups in CAPS-5 sum and subscale scores will be investigated. Test–retest reliability and inter-rater reliability will be determined. Internal consistency will be calculated using structural equation modeling (SEM) based internal consistency coefficients. Construct validity will be measured with Spearman’s rank correlation analyses and multivariate analyses of variance with Holm-Bonferroni corrected post hoc analysis of variances. In order to test diagnostic accuracy, receiver operating characteristics and sensitivity and specificity analyses will be conducted. The model structure of the German CAPS-5 will be analysed using confirmatory factor analyses.Ethics and disseminationThe study received ethical approval by the Ethics Committees of the Faculty of Psychology at the Ruhr-Universität Bochum (reference numbers: 331 and 358). The results of the study will be presented nationally and internationally at scientific conferences and will be published in scientific journals.Trial registration numberDRKS00015325


2018 ◽  
Vol 9 (1) ◽  
pp. 1546085 ◽  
Author(s):  
Manon A. Boeschoten ◽  
Niels Van der Aa ◽  
Anne Bakker ◽  
F. Jackie June Ter Heide ◽  
Marthe C. Hoofwijk ◽  
...  
Keyword(s):  
Dsm 5 ◽  

Sign in / Sign up

Export Citation Format

Share Document